Dasatinib and Venetoclax in Treating Patients With Philadelphia Chromosome Positive or BCR-ABL1 Positive Early Chronic Phase Chronic Myelogenous Leukemia (Q63807875)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Dasatinib and Venetoclax in Treating Patients With Philadelphia Chromosome Positive or BCR-ABL1 Positive Early Chronic Phase Chronic Myelogenous Leukemia |
clinical trial |
Statements
Therapy of Early Chronic Phase Chronic Myelogenous Leukemia (CML) With Dasatinib and Ventoclax: A Phase II Study (English)
0 references
19 February 2016
0 references
31 December 2040
0 references
140
0 references
18 year
0 references